
FDA Releases Artificial Intelligence/Machine Learning Action Plan
WASHINGTON, D.C. — The U.S. Food and Drug Administration released the agency’s first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a …
Read More